Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Suspensory Ligament Release

Ligamentolysis / Penile Suspensory Ligament Division for 'Lengthening'

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not an FDA-regulated device procedure; discouraged by major urology bodies

Reference only. Not medical advice.

What can go wrong

Documented complications: loss of erectile stability/'wobble' with the erection pointing downward, palpable scarring, penile retraction below baseline, hematoma, infection, altered sensation, and unsatisfactory cosmetic result. A change in the angle of erection is an intrinsic consequence, not a rare event. Re-scarring frequently negates the gain.

This is something to take to a clinician. The Atlas can tell you what is known about suspensory ligament release in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Division of the penile suspensory ligament releases the shaft from its attachment to the pubic symphysis, dropping it to a more dependent angle so more of the existing inner penis sits outside the body. The gain is largely illusory, the penis appears longer flaccid but stretched/erect gain is modest, and without spacer maintenance the ligament can re-scar and the penis retract. The American Urological Association states the procedure has not been shown to be safe or efficacious for cosmetic lengthening; the SMSNA 2024 position statement and EAU guidance similarly discourage cosmetic use.

The classic 'lengthening' operation that mostly relocates, not lengthens.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Cosmetic flaccid lengthening
  • Adjunct in micropenis reconstruction (different context)
  • Combined with girth procedures by cosmetic clinics

How it is supposed to work

The suspensory ligament tethers the dorsal base of the penis to the pubic bone. Dividing it lets the shaft hang lower, exposing buried proximal length. Because corporal tissue is not added, erect length is largely unchanged; the visible flaccid gain comes from a more obtuse pubic angle, which can also reduce upward erectile stability.

Why the gain retracts

Cut ligaments heal by scarring. Without a maintained spacer or traction, the scar tissue re-tethers the shaft, and many patients lose the early gain. Surgeons therefore pair the release with silicone spacers, fat pad work, or postoperative traction/extender protocols, meaning the durable result depends as much on the adjunct as on the cut itself.

Safety in detail

Elective cosmetic surgery discouraged for length augmentation by the AUA and SMSNA. Carries risks of erectile destabilization, retraction below baseline, and unsatisfactory cosmesis. Penile dysmorphic disorder should be excluded before any cosmetic genital surgery.

What people get wrong

  • Often saidIt lengthens the penis

    ActuallyIt mainly relocates and re-angles the existing penis; erect length is largely unchanged and flaccid gain can retract.

  • Often saidIt is a minor procedure

    ActuallyIt carries documented risks to erectile angle/stability, sensation, and cosmesis, and results can fall below baseline.

Who profits, and who pushes back

  • American Urological Association

    Pushes backProfessional society

    Division of the suspensory ligament for increasing penile length in adults has not been shown to be safe or efficacious.

What we do not know

  • Do traction-maintained releases produce durable measurable erect gain in controlled trials?
  • What fraction of patients end below baseline length after re-scarring?

At a glance

Mechanism
Relocates inner penis, changes angle
Typical reported flaccid gain
~1-2.5 cm
Erect gain
Minimal/none
AUA stance
Not shown safe or efficacious

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Suspensory Ligament Release. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • AUA position statement on penile augmentation surgeryongoing

    Suspensory ligament division for length increase 'has not been shown to be safe or efficacious'

  • Trost et al., SMSNA position statement, J Sex Med 21(6):5732024

    Reviews suspensory ligament division among cosmetic procedures; concludes data quality is low and expert opinion is the primary basis for any recommendation; mandates ruling out penile dysmorphic disorder

  • Campbell, review of penile elongation surgery, Transl Androl Urolreview

    Mainstay lengthening is partial suspensory release; erect-penis stability concerns raised by the surgical community